Pernix Therapeutics Holdings Inc (PTXTQ)

REAL ESTATE: REAL ESTATE INVESTMENT TRUSTS
SIC: PHARMACEUTICAL PREPARATIONS

10 NORTH PARK PLACE MORRISTOWN, NJ 07960

Golf Trust of America, Inc. As of Aug. 8, 2005, owned three properties which represent seven golf courses: four in Florida, two in South Carolina and one in New Mexico.
Pernix Therapeutics Holdings is a pharmaceutical company engaged in the sales, marketing and development of pharmaceutical products for pediatric and adult indications in a variety of therapeutic areas. Co. manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. Co.'s branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections; NATROBA, a treatment for head lice marketed under an agreement with ParaPRO, LLC;REZYST IM, a probiotic blend to promote dietary management; and a range of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX).

Data as of 2019-06-22 17:29:35 -0400
Market Cap308.978 Thousand Shares Outstanding14.506 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-6.366
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low2.65 / 0.017 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from PTXTQ instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PTXTQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PTXTQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PINA KENNETH SVP, GC,COMPLIANCE OFF & SEC

  • Officer
14,726 2019-01-05 0

SEDOR JOHN A CHAIRMAN OF BOARD AND CEO

  • Officer
  • Director
133,140 2018-08-08 0

WHALEY GLENN VP OF FIN, PAO & CONTROLLER

  • Officer
3,616 2018-08-08 0

SMITH ANGUS W. SVP, CBO & PRINCIPAL FIN OFF

  • Officer
8,018 2018-08-08 0

LANGER DENNIS

  • Director
0 2018-05-22 0

LEUNG GABRIEL

  • Director
0 2018-05-22 0

SWIRSKY DOUGLAS J

  • Director
0 2018-05-22 0

LEONE JOHN R

  • Director
0 2018-05-22 0

GOLEMBIEWSKI MICHAEL JOSEPH VP FINANCE, CONTROLLER, CAO

  • Officer
3,300 2017-08-08 0

MIAO GRAHAM G PRESIDENT AND CFO

  • Officer
  • Director
64,035 2017-08-08 0

ELMS STEVE

  • Director
0 2016-05-26 0

KONIDARIS TASOS

  • Director
0 2016-05-26 0

DRYSDALE DOUGLAS CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2016-02-25 0

NOVAK TERENCE CHIEF OPERATING OFFICER

  • Officer
0 2016-02-25 0

SHALABY RICK SVP COMMERCIAL OPERATIONS

  • Officer
0 2016-02-25 0

PATEL SANJAY S CHIEF FINANCIAL OFFICER

  • Officer
0 2016-02-25 0

SIEGEL BARRY J SENIOR VP AND GENERAL COUNSEL

  • Officer
0 2016-02-25 0

CLIFFORD TRACY SIMMONS PRINCIPAL ACCOUNTING OFFICER

  • Officer
7,506 2014-11-03 0

DORSEY BRIAN SVP RESEARCH

  • Officer
87,426 2014-10-10 0

SMITH JAMES EDWARD JR.

  • 10% Owner
3,501,704 2014-05-19 0

COLLINS COOPER C. CHIEF STRATEGIC OFFICER

  • Officer
3,526,571 2014-04-01 0

PEARCE MICHAEL COOPER PRESIDENT AND CEO

  • Officer
  • Director
286,667 2013-05-10 0

BECKER DAVID PAUL CHIEF FINANCIAL OFFICER

  • Officer
200,000 2012-12-07 0

BLANCHARD ANTHEM H.

  • Director
45,000 2012-03-22 0

HRUSHKA CHARLES S VP OF SALES AND MARKETING

  • Officer
0 2012-01-20 0

LOEB JAN H

  • Director
448,550 2011-03-11 0

VENTERS MICHAEL EXECUTIVE VP OF OPERATIONS

  • Officer
0 2010-05-12 0

GOTTLIEB JAY

  • Director
0 2010-01-03 0

COUCHMAN JONATHAN

  • Director
0 2010-01-03 0

VLAHOS WILLIAM

  • Director
  • 10% Owner
474,800 2008-05-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments